Antibacterial agents in preclinical programs worldwide by type 2021
In 2021, there were around 90 direct-acting small molecules in preclinical programs worldwide, as well as 33 direct acting peptides in preclinical programs. This statistic illustrates the number of antibacterial agents in preclinical programs worldwide, by agent category.